EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Evidence-Based Medicine 2006;11:9; doi:10.1136/ebm.11.1.9
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bial, A. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bial, A. K

Therapeutics

Review: limited evidence from 2 randomised controlled trials suggests that oral and intramuscular vitamin B12 have similar effectiveness for vitamin B12 deficiency

Vidal-Alaball J, Butler CC, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2005;(3):CD004655.

Q What is the relative effectiveness of oral and intramuscular (IM) vitamin B12 for vitamin B12 deficiency?

Clinical impact ratings GP/FP/Primary care ******{star} Geriatrics ******{star} Haematology *****{star}{star}

Key Words: vitamin B12 deficiency

The first 150 words of the full text of this article appear below.

METHODS
Formula Data sources: Cochrane Library (Issue 1, 2005), Medline (to Dec 2004), EMBASE/Excerpta Medica (to Dec 2004), Lilacs (to Dec 2004), National Research Register (UK), Current Controlled Trials, National Institutes of Health (USA), bibliographies of relevant papers, authors of relevant studies, experts in the field, and vitamin B12 manufacturers.

Formula Study selection and assessment: randomised controlled trials (RCTs) that compared the effects of oral and IM vitamin B12 in patients with low serum vitamin B12 concentrations who met criteria for replacement therapy (cut point of 180 pmol/l [240 pg/ml] for vitamin B12 deficiency). Studies of patients with primary folate deficiency or end stage renal disease or on haemodialysis, as well as studies of vitamin B12 for prevention of cardiovascular disease, were excluded. 2 researchers independently assessed the methodological quality of individual studies based on publication bias, selection bias, performance bias, attrition bias, and detection bias.

Formula Outcomes: serum vitamin B12 concentrations and clinical . . . [Full text of this article]

Andrea K Bial, MD

University of Chicago
Chicago, Illinois, USA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.